JP2009534294A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534294A5
JP2009534294A5 JP2008550095A JP2008550095A JP2009534294A5 JP 2009534294 A5 JP2009534294 A5 JP 2009534294A5 JP 2008550095 A JP2008550095 A JP 2008550095A JP 2008550095 A JP2008550095 A JP 2008550095A JP 2009534294 A5 JP2009534294 A5 JP 2009534294A5
Authority
JP
Japan
Prior art keywords
pioglitazone
salt
formulation
coating layer
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008550095A
Other languages
English (en)
Japanese (ja)
Other versions
JP5276991B2 (ja
JP2009534294A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008550095A priority Critical patent/JP5276991B2/ja
Priority claimed from JP2008550095A external-priority patent/JP5276991B2/ja
Publication of JP2009534294A publication Critical patent/JP2009534294A/ja
Publication of JP2009534294A5 publication Critical patent/JP2009534294A5/ja
Application granted granted Critical
Publication of JP5276991B2 publication Critical patent/JP5276991B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008550095A 2006-04-27 2007-04-26 固形製剤 Expired - Fee Related JP5276991B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008550095A JP5276991B2 (ja) 2006-04-27 2007-04-26 固形製剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006124456 2006-04-27
JP2006124456 2006-04-27
JP2008550095A JP5276991B2 (ja) 2006-04-27 2007-04-26 固形製剤
PCT/JP2007/059430 WO2007126136A2 (en) 2006-04-27 2007-04-26 Mask- tasting solid preparation of pioglitazone

Publications (3)

Publication Number Publication Date
JP2009534294A JP2009534294A (ja) 2009-09-24
JP2009534294A5 true JP2009534294A5 (https=) 2010-06-17
JP5276991B2 JP5276991B2 (ja) 2013-08-28

Family

ID=38655916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550095A Expired - Fee Related JP5276991B2 (ja) 2006-04-27 2007-04-26 固形製剤

Country Status (8)

Country Link
US (1) US8632808B2 (https=)
EP (1) EP2010154A2 (https=)
JP (1) JP5276991B2 (https=)
AR (1) AR060662A1 (https=)
CL (1) CL2007001194A1 (https=)
PE (1) PE20080249A1 (https=)
TW (1) TW200810753A (https=)
WO (1) WO2007126136A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE534374T1 (de) 2006-05-23 2011-12-15 Takeda Pharmaceutical Orale zubereitung mit pioglitazon
JP5683058B2 (ja) * 2007-04-27 2015-03-11 ニプロ株式会社 経口固形製剤及びその製造方法
TW200914006A (en) * 2007-07-12 2009-04-01 Takeda Pharmaceutical Coated preparation
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
JP2010202579A (ja) * 2009-03-03 2010-09-16 Sawai Pharmaceutical Co Ltd アカルボースを含有する口腔内崩壊剤
WO2011121824A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 口腔内崩壊錠
JP5614445B2 (ja) * 2010-03-29 2014-10-29 アステラス製薬株式会社 経口投与用粒子状医薬組成物
JP5566757B2 (ja) * 2010-04-16 2014-08-06 大塚製薬株式会社 固形製剤
WO2012156997A2 (en) * 2011-05-16 2012-11-22 Sun Pharma Advanced Research Company Ltd Multi-particulate pharmaceutical composition
CA2864068A1 (en) * 2012-02-15 2013-08-22 Takeda Pharmaceutical Company Limited Tablet comprising 1-(4-methoxybutyl)-n-(2-methylpropyl)-n-[(3s,5r)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1h-benzimidazole-2-carboxamide or a salt thereof
TW201340998A (zh) * 2012-02-29 2013-10-16 Takeda Pharmaceutical 經口劑
CN109820830A (zh) * 2012-03-02 2019-05-31 罗德兹制药股份有限公司 抗破坏性立即释放型制剂类
KR101340733B1 (ko) * 2012-12-31 2013-12-12 (주) 에프엔지리서치 신규한 마이크로그래뉼 제형
WO2014152351A1 (en) * 2013-03-15 2014-09-25 Boston Therapeutics, Inc. Encapsulation of pharmaceuticals for taste masking in chewable tablets
BR112016015944A8 (pt) * 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
JP6147711B2 (ja) * 2014-05-26 2017-06-14 富士フイルム株式会社 医薬用組成物及びその製造方法、並びに口腔内崩壊錠及びその製造方法
JP5764811B2 (ja) * 2014-06-18 2015-08-19 大塚製薬株式会社 固形製剤
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
EA038894B1 (ru) * 2018-06-08 2021-11-03 Айтен Садиг кызы Шукюрова Антидиабетическое лекарственное средство
AU2024334368A1 (en) * 2023-08-29 2026-04-02 Aclipse Two Inc. Pharmaceutical composition for use in the disease treatments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US5972373A (en) 1995-05-02 1999-10-26 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition for oral administration
TW585786B (en) * 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
JP3718398B2 (ja) 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
WO2002030400A1 (fr) 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
EP1552832A1 (en) 2002-07-11 2005-07-13 Takeda Pharmaceutical Company Limited Process for producing coated preparation
IN192749B (https=) * 2002-11-15 2004-05-15 Ranbaxy Lab Ltd
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2009534294A5 (https=)
JP7028829B2 (ja) 口腔内崩壊錠及びその製造方法
JP6040218B2 (ja) 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
NZ728442A (en) Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
PT1830855E (pt) Formas de apresentação farmacêuticas sólidas, para administração oral, contendo ritaroxaban com libertação modificada
JP2016516698A5 (https=)
RU2004101061A (ru) Фармацевтический препарат, содержащий ингибитор протонной помпы и антациды
JP2006514100A5 (https=)
RU2010153904A (ru) Ниацин-содержащие композиции с модифицированным высвобождением
JP2008531742A5 (https=)
JP2016513625A5 (https=)
JP5614445B2 (ja) 経口投与用粒子状医薬組成物
CN103751139A (zh) 鲁拉西酮口腔崩解片
JP6204141B2 (ja) 口腔内速崩壊性固形製剤用組成物
JP2009532434A5 (https=)
RU2018137590A (ru) Фармацевтические композиции для производного n-пропаргиламина
CN103930094A (zh) 即释4-甲基-3[[4-(3-吡啶基)-2-嘧啶基]氨基]-n-[5-(4-甲基-1h-咪唑-1-基)-3-(三氟甲基)苯基]苯甲酰胺剂型
JP4691925B2 (ja) 圧縮成型製剤の製造方法
JP2016516031A5 (https=)
CA2885623C (en) Oral preparation and method for producing the same
JP2008500365A5 (https=)
JP6476122B2 (ja) 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP2010529125A5 (https=)
JP6340325B2 (ja) ナフトピジル含有口腔内崩壊錠
JP2011213695A (ja) ドネペジル塩酸塩含有口腔内速崩壊錠